Fundraising FoxTwo Sigma Ventures — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.
AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US
Chris Gibson(Co-founder and Chairman of the Board)inBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)Najat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)
Co-investorsDCVC (Data Collective)Lux CapitalBaillie GiffordAdvantage Capital PartnersAir Street CapitalAmplify Partners+22 more
An insurance brokerage offering personalized policy solutions for small businesses across multiple sectors including healthcare providers, attorneys, dentists, and nonprofits.
InsurTechNew York, US
Inaki Berenguer(Founder)inInaki Berenguer Rashmi Melgiri(Founder)Rashag Jhunjhunwala(Founder)
BoardCharles Moldow(Director)inJohn Buttrick(Director)
Co-investorsDeviation CapitalFoundation CapitalFounder CollectiveKibo VenturesKleiner PerkinsR136 Ventures+6 more
New York, US
Colin Beirne(Director)Adam Simowitz-Price(Executive Officer, Director, Promoter)Jeffrey Silverman(Director)in
Co-investorsAlpine MeridianFJ LabsLaconiaLerer HippeauRSE Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.